Peter Canney - Concepedia

Author

Peter Canney

Also Known As

C. Cunningham, P A Canney, P CANNEY, P Canney, P, Canney, P. Canney, P.A Canney, P.A. CANNEY, P.A. Canney, Peter A Canney

111

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Beatson West of Scotland Cancer Centre Western Infirmary Weston Park Cancer Centre University College London The Christie Hospital

About

Peter Canney is an author at Beatson West of Scotland Cancer Centre specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.5K
2	Health Sciences	4	4	245
3	Nursing	1	1	82
4	Public Health	1	1	12
5	Cell Biology	1	1	12

Peter Canney

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker Peter Canney, Michael Moore, P M Wilkinson, British Journal of Cancer Tumour MarkerOncologyProspective Clinical AssessmentTumoral PathologyMedicine	1984	319
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring Anna Jones, Malcolm Barlow, Peter Barrett‐Lee, British Journal of Cancer	2009	215
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others John M.S. Bartlett, Jane Bayani, Andrea Marshall, JNCI Journal of the National Cancer Institute	2016	210
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer A M Al Murri, J. M. S. Bartlett, Peter Canney, British Journal of Cancer	2006	200
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial Peter Barrett‐Lee, Lindsay Johnson, David Cameron, The Lancet Breast OncologyOncologyPhase IiiClinical TrialsAdjuvant Chemotherapy	2009	188
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Heikki Joensuu, Judith Fraser, Hans Wildiers, JAMA Oncology	2018	145
Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy? Peter Canney, Stephen Dean British Journal of Radiology	1990	131
A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer Carol MacGregor, Peter Canney, G. A. Patterson, European Journal of Cancer Breast OncologyEarly Breast CancerMedicineOral Soy SupplementsRandomised Double-blind	2005	110
Early closure of a randomized trial: Surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumours Andrew Robertson, David S. Soutar, James Paul, Clinical Oncology Surgical OncologyRadiation TherapyEarly ClosureMedicineSurgery	1998	94
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation Leila Rooshenas, Lauren J Scott, Jane Blazeby, Journal of Clinical Epidemiology	2018	90

Page 1